Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 3/20 | 0.36 |
| ▸ | PPARA | Q07869 | 3/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | LIPE | Q05469 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.35 |
| ▸ | GABRP | O00591 | 1/20 | 0.35 |
| ▸ | GABRD | O14764 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6309149 | 0.82 | PTGDR2 (0.36) | PPARGPTGDR2 | |
| SCHEMBL8819121 | 0.81 | CFTR (0.46) | CFTRKDM4EMRGPRX4BCHEACHE | |
| SCHEMBL6707271 | 0.80 | CFTR (0.45) | CFTRKDM4ETP53MRGPRX4PTGDR2 | |
| SCHEMBL6293326 | 0.78 | DHODH (0.39) | PPARGDHODHPTGDR2 | |
| SCHEMBL5408510 | 0.75 | KDM4E (0.39) | KDM4EMRGPRX4PPARDPPARAPPARG | |
| SCHEMBL5833100 | 0.73 | CFTR (0.58) | CFTRKDM4EMRGPRX4PPARDPPARA | |
| SCHEMBL25085889 | 0.73 | CFTR (0.65) | CFTRKDM4EMRGPRX4PPARDPPARA | |
| SCHEMBL5419988 | 0.72 | PPARD (0.41) | KDM4EMRGPRX4PPARDPPARAPPARG | |
| SCHEMBL5841660 | 0.70 | CFTR (0.61) | CFTRKDM4EMRGPRX4LMNARECQL | |
| SCHEMBL5833870 | 0.70 | CFTR (0.61) | CFTRKDM4EMRGPRX4LMNARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050079979-A1 | Substituted benzoylisoxazoles and the use thereof as herbicides | MULLER KLAUS-HELMUT (DE) | 2005-04-14 | — | — | US | disclosed |
| US-6838415-B1 | Substituted benzoylisoxazoles and the use thereof as herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 2005-01-04 | — | — | US | disclosed |
| EP-1178987-B1 | SUBSTITUTED BENZOYLISOXAZOLES AND THE USE THEREOF AS HERBICIDES | BAYER CROPSCIENCE AG (DE) | 2003-08-13 | — | — | EP | disclosed |
| CN-1349532-A | Substituted benzoyl isoxazoles and their use as herbicides | BAYER AG (DE) | 2002-05-15 | — | — | CN | disclosed |
| EP-1178987-A1 | SUBSTITUTED BENZOYLISOXAZOLES AND THE USE THEREOF AS HERBICIDES | Bayer Aktiengesellschaft (DE) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000068227-A1 | SUBSTITUTED BENZOYLISOXAZOLES AND THE USE THEREOF AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050079979-A1 | Substituted benzoylisoxazoles and the use thereof as herbicides | CYP4X1, DDT, GLRX3 | CFTR 1795/4885KDM4E 2045/4885TP53 2881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.